Insulin‑like growth factor axis: A potential nanotherapy target for resistant cervical cancer tumors (Review).

Autor: Morales-Rodríguez M; Directorate of The Nanotechnology Engineering Division, Polytechnic University of The Valley of Mexico, Tultitlán, State of Mexico 54910, Mexico.; Nanotechnology and Biotechnology Engineering Division, Polytechnic University of The Valley of Mexico, Tultitlán, State of Mexico 54910, Mexico., Paniagua-García L; Department of Biological Sciences, Section of Human Health Sciences, National Autonomous University of Mexico, Faculty of Advanced Studies Cuautitlán C1, Cuautitlán Izcalli, State of Mexico 54740, Mexico., Narayanan J; Nanotechnology and Biotechnology Engineering Division, Polytechnic University of The Valley of Mexico, Tultitlán, State of Mexico 54910, Mexico., Zamudio-Meza H; Immunochemistry Medical Research Unit, Specialty Hospital National Medical Center 'Siglo XXI' Mexican Social Security Institute, Mexico City 06720, Mexico., Moreno-Torres RV; Microbial Ecology Laboratory, Unidad de Biotecnología y Prototipos-UBIPRO, National Autonomous University of Mexico, Faculty of Advanced Studies Iztacala Tlalnepantla de Baz, State of Mexico 54090, Mexico., Cortés-González CC; Biomedical Unit for Cancer Research, Department of Basic Research, Biomedical Research Institute, National Autonomous University of Mexico/National Cancer Institute, Mexico City 14080, Mexico., Juanico-Lorán JA; Nanotechnology and Biotechnology Engineering Division, Polytechnic University of The Valley of Mexico, Tultitlán, State of Mexico 54910, Mexico., Martínez-Pérez B; Nanotechnology and Biotechnology Engineering Division, Polytechnic University of The Valley of Mexico, Tultitlán, State of Mexico 54910, Mexico.; Nanobiotechnology Laboratory, Nanotechnology and Biotechnology Engineering Division, Polytechnic University of the Valley of Mexico, Tultitlán, State of Mexico 54910, Mexico., Fernández-Retana J; Nanotechnology and Biotechnology Engineering Division, Polytechnic University of The Valley of Mexico, Tultitlán, State of Mexico 54910, Mexico.; Nanobiotechnology Laboratory, Nanotechnology and Biotechnology Engineering Division, Polytechnic University of the Valley of Mexico, Tultitlán, State of Mexico 54910, Mexico.
Jazyk: angličtina
Zdroj: Oncology letters [Oncol Lett] 2023 Feb 10; Vol. 25 (3), pp. 128. Date of Electronic Publication: 2023 Feb 10 (Print Publication: 2023).
DOI: 10.3892/ol.2023.13714
Abstrakt: Cervical cancer is among the most frequently occurring neoplasms worldwide, and it particularly affects individuals in developing countries. Factors such as the low quality of screening tests, the high incidence of locally advanced cancer stages and the intrinsic resistance of certain tumors are the main causes of failure in the treatment of this neoplasm. Due to advances in the understanding of carcinogenic mechanisms and bioengineering research, advanced biological nanomaterials have been manufactured. The insulin-like growth factor (IGF) system comprises multiple growth factor receptors, including IGF receptor 1. These receptors are activated by binding to their respective growth factor ligands, IGF-1 and IGF-2, and insulin, and play an important role in the development, maintenance, progression, survival and treatment resistance of cervical cancer. In the present review, the role of the IGF system in cervical cancer and three nanotechnological applications that use elements of this system are described, namely Trap decoys, magnetic iron oxide nanoparticles and protein nanotubes. Their use in the treatment of resistant cervical cancer tumors is also discussed.
Competing Interests: The authors declare that they have no competing interests.
(Copyright: © Morales-Rodríguez et al.)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje